Brendan O'Grady
Chief Executive Officer presso AUSPEX PHARMACEUTICALS INC
Profilo
Brendan O'Grady is currently the Chief Executive Officer at Auspex Pharmaceuticals, Inc. and also serves as a Director at the Association for Accessible Medicines.
He previously worked as a Director at the Pharmaceutical Research & Manufacturers of America.
From 2011 to 2021, he worked at Teva Pharmaceutical Industries Ltd.
and served as the EVP-North America Commercial Division from 2017 to 2021.
He also worked as the Chief Commercial & Growth Officer at American Well Corp.
from 2015 to 2022.
Mr. O'Grady holds an MBA from Baker University and an undergraduate degree from the State University of New York College at Geneseo.
Posizioni attive di Brendan O'Grady
Società | Posizione | Inizio |
---|---|---|
AUSPEX PHARMACEUTICALS INC | Chief Executive Officer | - |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Director/Board Member | - |
Precedenti posizioni note di Brendan O'Grady
Società | Posizione | Fine |
---|---|---|
AMERICAN WELL CORPORATION | Director/Board Member | 19/07/2021 |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 15/08/2021 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | - |
Formazione di Brendan O'Grady
Baker University | Masters Business Admin |
State University of New York College at Geneseo | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
AMERICAN WELL CORPORATION | Technology Services |
Aziende private | 3 |
---|---|
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Brendan O'Grady